Logo

UCB Pharma to Use Entelos PhysioLab for Rheumatoid Arthritis Research

Jan 21, 2008
NEW YORK (GenomeWeb News) - Entelos said today that UCB Pharma will use its PhysioLab biosimulation platform for rheumatoid arthritis research.
 
The Rheumatoid Arthritis PhysioLab is a predictive computer model that simulates arthritic patients and drug effects.
 
The company said that researchers use the system to select targets and compounds, find the best doses for patients, and support clinical trial design.
 
Financial terms of the agreement were not disclosed.

Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.